Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9265 - 9272 of 12089 results
Obama Administration Unveils Clean Power Plan
August 4, 2015| Blog| Viewpoint
Massachusetts Appeals Court Set to Consider Scope of Employer Liability for Employee Data Breaches
August 4, 2015| Blog| Viewpoint
West Virginia AG Clears Merger Creating Second Largest Hospital Chain in the State with Conduct Remedy
August 3, 2015| Alert| Viewpoint
363 Sale Denied because Secured Creditor not Paid in Full from Proceeds
August 3, 2015| Blog| Viewpoint
OIG Issues Favorable Advisory Opinion of Hospital Leasing Arrangement
August 3, 2015| Blog| Viewpoint
Privacy Monday - August 3, 2015
August 3, 2015| Blog| Viewpoint
Commil USA V. Cisco Systems: “I thought it was legal” is no defense to induced infringement under 35 U.S.C. § 271(b)
August 3, 2015| Advisory| Viewpoint
Federal Circuit Clarifies Standard for Prior Art in Obviousness Analysis
July 31, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|